Genetic variants in major depressive disorder: From pathophysiology to therapy.

Abstract excerpt

In spite of promising preclinical results there is a decreasing number of new registered medications in major depression. The main reason behind this fact is the lack of confirmation in clinical studies for the assumed, and in animals confirmed, therapeutic results. This suggests low predictive value of animal studies for central nervous system disorders. One solution for identifying new possible targets is the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Epistasis, Genetic
• Share to Antidepressive Agents